Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In some cases, slowing the titration schedule under medical supervision can meaningfully reduce side-effect burden without compromising therapeutic benefit
Medically reviewed 27/04/26 by Roger Compton (GPhC 2082993), M.Pharm
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
$350 to $550: both are viable
A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder
Dicker, G
US$ 29.59
US$ 27.00
US$ 20.53
US$ 22.30
US$ 23.59
US$ 24.97
US$ 23.34
US$ 22.66
US$ 24.38
